• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

黄芪甲苷通过 TGF-β 调节的 Akt/Foxo1 通路拮抗巨噬细胞 M2 极化诱导的乳腺癌恶性进展。

Astragaloside IV antagonizes the malignant progression of breast cancer induced by macrophage M2 polarization through the TGF-β-regulated Akt/Foxo1 pathway.

机构信息

The First Affiliated Hospital of Baotou Medical College of Inner Mongolia University of Science and Technology, China.

Baotou Medical College of Inner Mongolia University of Science and Technology, China.

出版信息

Pathol Res Pract. 2023 Sep;249:154766. doi: 10.1016/j.prp.2023.154766. Epub 2023 Aug 14.

DOI:10.1016/j.prp.2023.154766
PMID:37633006
Abstract

BACKGROUND

Astragaloside IV (AS‑IV) was used for breast cancer (BC) treatment in China from ancient times; however, the mechanism of the prevention effect of AS-IV on BC remains not entirely clear.

METHODS

qRT-PCR, western blot and flow cytometry were employed to validate the expression of gene and protein expressions. CCK-8 assay, scratch assay, and transwell assay were used to assess the BC cell proliferation, migration, and invasion. Co-culture of conditional medium from macrophages and BC were performed.

RESULTS

AS-IV suppressed macrophage polarized to M2 phenotype and thereby inhibited M2 macrophage-induced BC progression. The inhibitory effect of AS-IV on M2 macrophage polarization was exerted via the deactivation of the Akt/Foxo1 signaling pathway in macrophages by suppressing TGF-β. The addition of TGF-β or the treatment with Akt activator SC79 reversed the regulatory effect of AS-IV on M2 macrophage polarization, which increased M2 macrophage polarization-induced BC cell proliferation, migration and invasion.

CONCLUSION

This present study revealed a new mechanism of AS-IV inhibited M2 macrophage polarization-induced BC progression and may provide a potential target for the treatment of BC.

摘要

背景

从古代开始,黄芪甲苷(AS-IV)就被用于治疗乳腺癌(BC);然而,AS-IV 预防 BC 的作用机制尚不完全清楚。

方法

采用 qRT-PCR、western blot 和流式细胞术验证基因和蛋白表达。用 CCK-8 检测、划痕实验和 Transwell 检测评估 BC 细胞增殖、迁移和侵袭。进行巨噬细胞条件培养基与 BC 的共培养。

结果

AS-IV 抑制巨噬细胞向 M2 表型极化,从而抑制 M2 巨噬细胞诱导的 BC 进展。AS-IV 对 M2 巨噬细胞极化的抑制作用是通过抑制 TGF-β来激活巨噬细胞中的 Akt/Foxo1 信号通路来发挥的。添加 TGF-β或用 Akt 激活剂 SC79 处理可逆转 AS-IV 对 M2 巨噬细胞极化的调节作用,从而增加 M2 巨噬细胞极化诱导的 BC 细胞增殖、迁移和侵袭。

结论

本研究揭示了 AS-IV 抑制 M2 巨噬细胞极化诱导的 BC 进展的新机制,可为 BC 的治疗提供潜在靶点。

相似文献

1
Astragaloside IV antagonizes the malignant progression of breast cancer induced by macrophage M2 polarization through the TGF-β-regulated Akt/Foxo1 pathway.黄芪甲苷通过 TGF-β 调节的 Akt/Foxo1 通路拮抗巨噬细胞 M2 极化诱导的乳腺癌恶性进展。
Pathol Res Pract. 2023 Sep;249:154766. doi: 10.1016/j.prp.2023.154766. Epub 2023 Aug 14.
2
Astragaloside IV antagonizes M2 phenotype macrophage polarization-evoked ovarian cancer cell malignant progression by suppressing the HMGB1-TLR4 axis.黄芪甲苷通过抑制 HMGB1-TLR4 轴拮抗 M2 表型巨噬细胞极化诱导的卵巢癌细胞恶性进展。
Mol Immunol. 2021 Feb;130:113-121. doi: 10.1016/j.molimm.2020.11.014. Epub 2020 Dec 9.
3
MSC-secreted TGF-β regulates lipopolysaccharide-stimulated macrophage M2-like polarization via the Akt/FoxO1 pathway.MSC 分泌的 TGF-β 通过 Akt/FoxO1 通路调节脂多糖刺激的巨噬细胞 M2 样极化。
Stem Cell Res Ther. 2019 Nov 26;10(1):345. doi: 10.1186/s13287-019-1447-y.
4
Astragaloside IV inhibits lung cancer progression and metastasis by modulating macrophage polarization through AMPK signaling.黄芪甲苷通过调节 AMPK 信号通路抑制巨噬细胞极化从而抑制肺癌的进展和转移。
J Exp Clin Cancer Res. 2018 Aug 29;37(1):207. doi: 10.1186/s13046-018-0878-0.
5
Astragaloside IV inhibits the progression of liver cancer by modulating macrophage polarization through the TLR4/NF-κB/STAT3 signaling pathway.黄芪甲苷IV通过TLR4/NF-κB/STAT3信号通路调节巨噬细胞极化来抑制肝癌进展。
Am J Transl Res. 2022 Mar 15;14(3):1551-1566. eCollection 2022.
6
Astragaloside IV suppresses the migration and EMT progression of cervical cancer cells by inhibiting macrophage M2 polarization through TGFβ/Smad2/3 signaling.黄芪甲苷通过 TGFβ/Smad2/3 信号通路抑制巨噬细胞 M2 极化抑制宫颈癌迁移和 EMT 进展。
Funct Integr Genomics. 2023 Apr 21;23(2):133. doi: 10.1007/s10142-023-01017-z.
7
Tumor-derived exosomal miR-148b-3p mediates M2 macrophage polarization via TSC2/mTORC1 to promote breast cancer migration and invasion.肿瘤来源的外泌体 miR-148b-3p 通过 TSC2/mTORC1 介导 M2 巨噬细胞极化,促进乳腺癌迁移和侵袭。
Thorac Cancer. 2023 Jun;14(16):1477-1491. doi: 10.1111/1759-7714.14891. Epub 2023 May 5.
8
Curcumin Suppresses M2 Macrophage-derived Paclitaxel Chemoresistance through Inhibition of PI3K-AKT/STAT3 Signaling.姜黄素通过抑制 PI3K-AKT/STAT3 信号通路抑制 M2 型巨噬细胞来源的紫杉醇耐药性。
Anticancer Agents Med Chem. 2024;24(2):146-156. doi: 10.2174/0118715206275259231105184959.
9
Down-regulated paxillin suppresses cell proliferation and invasion by inhibiting M2 macrophage polarization in colon cancer.下调的桩蛋白通过抑制结肠癌中 M2 巨噬细胞极化来抑制细胞增殖和侵袭。
Biol Chem. 2018 Oct 25;399(11):1285-1295. doi: 10.1515/hsz-2018-0002.
10
m6A Modification Mediates Exosomal LINC00657 to Trigger Breast Cancer Progression Via Inducing Macrophage M2 Polarization.m6A 修饰介导外泌体 LINC00657 通过诱导巨噬细胞 M2 极化触发乳腺癌进展。
Clin Breast Cancer. 2023 Jul;23(5):546-560. doi: 10.1016/j.clbc.2023.04.007. Epub 2023 May 15.

引用本文的文献

1
Traditional Chinese medicine in the treatment of breast Cancer.中医治疗乳腺癌
Mol Cancer. 2025 Aug 1;24(1):209. doi: 10.1186/s12943-025-02416-5.
2
Nanoparticle technologies in precision oncology and personalized vaccine development: Challenges and advances.精准肿瘤学和个性化疫苗开发中的纳米颗粒技术:挑战与进展
Int J Pharm X. 2025 Jul 5;10:100353. doi: 10.1016/j.ijpx.2025.100353. eCollection 2025 Dec.
3
Macrophage polarization in disease therapy: insights from astragaloside IV and cycloastragenol.疾病治疗中的巨噬细胞极化:黄芪甲苷和环黄芪醇的启示
Front Pharmacol. 2025 May 23;16:1598022. doi: 10.3389/fphar.2025.1598022. eCollection 2025.
4
Natural saponins and macrophage polarization: Mechanistic insights and therapeutic perspectives in disease management.天然皂苷与巨噬细胞极化:疾病管理中的机制洞察与治疗前景
Front Pharmacol. 2025 May 9;16:1584035. doi: 10.3389/fphar.2025.1584035. eCollection 2025.
5
Reprogramming the breast tumor immune microenvironment: cold-to-hot transition for enhanced immunotherapy.重编程乳腺肿瘤免疫微环境:从冷到热的转变以增强免疫治疗
J Exp Clin Cancer Res. 2025 Apr 25;44(1):131. doi: 10.1186/s13046-025-03394-8.
6
Macrophage subtypes inhibit breast cancer proliferation in culture.巨噬细胞亚型在培养中抑制乳腺癌增殖。
Mol Biol Cell. 2025 Jan 1;36(1):br2. doi: 10.1091/mbc.E24-06-0241. Epub 2024 Nov 27.
7
: A Traditional Chinese Medicine with Multifaceted Impacts on Breast Cancer Treatment.一种对乳腺癌治疗具有多方面影响的中药。
Biomolecules. 2024 Oct 21;14(10):1339. doi: 10.3390/biom14101339.
8
Astragaloside IV augments anti-PD-1 therapy to suppress tumor growth in lung cancer by remodeling the tumor microenvironment.黄芪甲苷通过重塑肿瘤微环境增强抗 PD-1 治疗抑制肺癌肿瘤生长。
Eur J Histochem. 2024 Oct 23;68(4):4098. doi: 10.4081/ejh.2024.4098.
9
Research Progress on the Anti-Cancer Effects of Saponins and Their Mechanisms of Action.皂苷的抗肿瘤作用及其作用机制的研究进展。
Molecules. 2024 Jul 18;29(14):3388. doi: 10.3390/molecules29143388.
10
Macrophage subtypes inhibit breast cancer proliferation in culture.巨噬细胞亚型在培养中抑制乳腺癌增殖。
bioRxiv. 2024 Jun 1:2024.06.01.596963. doi: 10.1101/2024.06.01.596963.